Stay updated on Tagraxofusp in Secondary AML Clinical Trial
Sign up to get notified when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.

Latest updates to the Tagraxofusp in Secondary AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedUI label capitalization was updated from 'Find Contact Information' to 'Find contact information'. A new 'Revision: v3.7.0' badge appears, replacing the previous version indicator.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe study record history now lists the latest revision as v3.6.6, replacing the previous version v3.6.5.SummaryDifference0.1%

- Check56 days agoChange DetectedThe study record history now includes a new revision entry v3.6.5. The previous revision v3.6.4 has been removed.SummaryDifference0.1%

- Check70 days agoChange DetectedA new Revision: v3.6.4 entry was added and the previous Revision: v3.6.3 entry was removed in the study record history, indicating a small backend/UI update reflected in the log.SummaryDifference0.1%

- Check84 days agoChange DetectedThe history section now includes new entries for eligibility and study status, with a latest version noted as 27 around 2026-07-09 and an entry for 2026-07-10; an older entry from 2026-04-08 has been removed.SummaryDifference0.4%

- Check91 days agoChange DetectedRevision label updated to v3.6.3 in the page history, replacing the previous v3.6.2. This reflects a minor update to the page rendering or metadata for the study record, without changes to the study data.SummaryDifference0.1%

Stay in the know with updates to Tagraxofusp in Secondary AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.